Effects of the V2-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 1, 2000, Pages 288-294

  Hirano, Takahiro ^a   Yamamura, Yoshitaka ^a   Nakamura, Shigeki ^a   Onogawa, Toshiyuki ^a   Mori, Toyoki ^a  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; FUROSEMIDE; SODIUM; TOLVAPTAN; UNCLASSIFIED DRUG; VASOPRESSIN ANTAGONIST; VASOPRESSIN V2 RECEPTOR;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIURESIS; DOSE RESPONSE; DRUG MEGADOSE; MALE; NATRIURESIS; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SERUM OSMOLALITY; SODIUM BLOOD LEVEL; URINE VOLUME;

ALDOSTERONE; ANIMALS; BENZAZEPINES; DIURESIS; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ELECTROLYTES; FUROSEMIDE; HORMONES; MALE; OSMOLAR CONCENTRATION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN; RENIN; SODIUM; WATER;

EID: 0033965154     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Abe K, Yasujima M, Chiba S, Irokawa N, Ito T and Yoshinaga K (1977) Effect of furosemide on urinary excretion of prostaglandin E in normal volunteers and patients with essential hypertension. Prostaglandins 14:513-521.
2. Anand IS, Kalra GS, Harris P, Poole-Wilson PA, Panzali A, De-Giuri F and Ferrari R (1991) Diuretics as initial and sole treatment in chronic cardiac failure. Cardioscience 2:273-278.
3. Bailie MD, Crosslan K and Hook JB (1976) Natriuretic effect of furosemide after inhibition of prostaglandin synthetase. J Pharmacol Exp Ther 199:469-476.
4. 2 in isolated rat glomeruli. Am J Physiol 243:F276-F283.
5. Berl T and Schrier RW (1986) Disorders of water metabolism, in Renal and Electrolyte Disorders (Schrier RW ed) pp 1-77, Brown and Company, Boston, MA.
6. Chabardes D, Gagman-Brunette M, Imbert-Teboul M, Gontcharevskaia O, Montegut M, Clioue A and Morel F (1980) Adenylate cyclase responsiveness to hormones in various portions of the human nephron. J Clin Invest 65:439-448.
7. Chabardes D, Imbert-Teboul M, Gagnan-Brunette M and Morel F (1977) Difference hormone target sites along the mouse and rabbit nephrons. Curr Probl Clin Biochem 8:447-454.
8. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB and Cohn JN (1985) Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Ann Intern Med 103:1-6.
9. Hall DA and Varney DM (1980) Effect of vasopressin electrical potential difference and chloride transport in mouse medullary thick ascending limb of Henle. J Clin Invest 66:792-802.
10. Hayashi Y, Hisa H and Satoh S (1987) Role of prostaglandin in norepinephrine and renin release in canine kidney. Am J Physiol 253:F929-F934.
11. 2 receptor antagonist, in anesthetized dogs (Abstract). Jpn J Pharmacol 64:255.
12. Kinter LB, Dubb J, Huffman W, Brennan F and Stassen F (1985) Potential role of vasopressin antagonists in treatment of water-retaining disorders, in Vasopressin (Schrier RW ed) pp 553-561, Raven Press, New York.
13. Kinter LB, Dytko G, Ashton D, MacDonald J, Huffman W and Stassen F (1986) Discovery and therapeutic utility of vasopressin antagonists in rats. J Cardiovasc Pharmacol 8:S36-S43.
14. Kinter LB, Mann W, Heckman G, Huffman W, Gross M and Stassen F (1984) Vasopressin antagonist-associated aquaresis in dogs (Abstract). Kidney Int 24:304.
15. Kondo K, Ogawa H, Yamashita H, Miyamoto H, Tanaka M, Nakaya K, Kitano K, Yamamura Y, Nakamura S, Onogawa T, Mori T and Tominaga M (1999) 7-Chloro5-hydroxy-1-[2-methyl-4-(2-methylbenzoyl-amino)benoyl]-2,3,4,5- tetrahydro-1H-1-benzazepine (OPC-41061): A potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist. Bioorg Med Chem 7:1743-1754.
16. Lorenz JN, Weihprecht H, Schnermann J, Skøtt O and Briggs JP (1991) Renin release from isolated juxtaglomerular apparatus depends on macula densa chloride transport. Am J Physiol 260:F486-F493.
17. Mallie JP, Bichet DG and Halperin ML (1997) Effective water clearance and tonicity balance: The excretion of water revisited. Clin Invest Med 20:16-24.
18. Morel F (1981) Sites of hormone action in the mammalian nephron. Am J Physiol 240:F159-F164.
19. Morrison RT (1997) Edema and principles of diuretic use. Med Clin N Am 81:689-704.
20. Ogawa H, Yamashita H, Kondo K, Yamamura Y, Miyamoto H, Kan K, Kitano K, Tanaka M, Nakaya K, Nakamura S, Mori T, Tominaga M and Yabuuchi Y (1996) Orally active, nonpeptide vasopressin V2 receptor antagonists: A novel series of 1-[4-(benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepines and related compounds. J Med Chem 39:3547-3555.
21. Padfield PL and Morton JJ (1977) Effects of angiotensin II on arginine vasopressin in physiological and pathological situations in man. J Endocrinol 74:251-259.
22. Robertson GL, Mahr EA, Athar S and Sinha T (1973) Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 52:2340-2352.
23. Robertson GL, Shelton RL and Athar S (1976) The osmoregulation of vasopressin. Kidney Int 10:25-37.
24. Romano G, Favret G and Bartoli E (1995) Micropuncture study of the effect of furosemide on proximal and distal tubules of the rat nephron. Renal Physiol Biochem 18:209-218.
25. Ruggles BT, Murayama N, Werness JL, Gapstur SM, Bentley MD and Dousa TP (1985) The vasopressin-sensitive adenylate cyclase in collecting tubules and in the thick ascending limbs of Henle's loop of human and canine kidney. J Clin Endocrinol Metab 60:914-921.
26. Shoker AS (1994) Application of the clearance concept to hyponatremic and hypernatremic disorders: A phenomenological analysis. Clin Chem 40:1220-1270.
27. Sladek CD, Blair ML and Ramsey DJ (1982) Further studies on the role of angiotensin in the osmotic control of vasopressin release by the organ-cultured rat hypothalamo-neurohypophyseal system. Endocrinology 111:599-607.
28. Tenstad O and Williamson HE (1995) Effect of furosemide on local and zonal gromerular filtration rate in the rat kidney. Acta Physiol Scand 155:99-107.
29. Whorton AR, Lazar JD, Smigel MD and Oates JA (1980) Prostaglandin-mediated renin release from renal cortical slices, in Advances in Prostaglandin and Thromboxane Research (Samuelsson B, Ramwell P and Paoletti R eds) pp 1123-1129, Raven, New York.
30. Williamson HE, Bourland WA, Marchand GR, Farley DB and Van Orden DE (1975) Furosemide induced release of prostaglandin E to increase renal blood flow. Proc Soc Exp Biol Med 150:104-106.
31. 2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther 287:860-867.
32. 2 receptor antagonist. Br J Pharmacol 105: 787-791.
33. 2 antagonist, on renal function in anesthetized dogs (Abstract). Jpn J Pharmacol 61:275.